Tissue kallikrein is a serine protease thought to be involved in the genera
tion of bioactive peptide kinins in many organs like the kidneys, colon, sa
livary glands, pancreas, and blood vessels. Low renal synthesis and urinary
excretion of tissue kallikrein have been repeatedly linked to hypertension
in animals and humans, but the exact role of the protease in cardiovascula
r function has not been established largely because of the lack of specific
inhibitors. This study demonstrates that mice lacking tissue kallikrein ar
e unable to generate significant levels of kinins in most tissues and devel
op cardiovascular abnormalities early in adulthood despite normal blood pre
ssure. The heart exhibits septum and posterior wall thinning and a tendency
to dilatation resulting in reduced left ventricular mass. Cardiac function
estimated in vivo and in vitro is decreased both under basal conditions an
d in response to beta -adrenergic stimulation. Furthermore, flow-induced va
sodilatation is impaired in isolated perfused carotid arteries, which expre
ss, like the heart, low levels of the protease. These data show that tissue
kallikrein is the main kinin-generating enzyme in vivo and that a function
al kallikrein-kinin system is necessary for normal cardiac and arterial fun
ction in the mouse. They suggest that the kallikrein-kinin system could be
involved in the development or progression of cardiovascular diseases.